Arlinghaus RB - Search Results

1

Current status of the BCR gene and its involvement with human leukemia.

Campbell ML, Arlinghaus RB. Campbell ML, et al. Among authors: arlinghaus rb. Adv Cancer Res. 1991;57:227-56. doi: 10.1016/s0065-230x(08)61000-3. Adv Cancer Res. 1991. PMID: 1950704 Review. No abstract available.

2

Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL.

Lu D, Liu J, Campbell M, Guo JQ, Heisterkamp N, Groffen J, Canaani E, Arlinghaus R. Lu D, et al. Blood. 1993 Aug 15;82(4):1257-63. Blood. 1993. PMID: 8353288 Free article.

3

P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.

Campbell ML, Li W, Arlinghaus RB. Campbell ML, et al. Among authors: arlinghaus rb. Oncogene. 1990 May;5(5):773-6. Oncogene. 1990. PMID: 2140598

4

Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.

Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt SA, McCredie KB, Campbell ML, Arlinghaus RB. Guo JQ, et al. Among authors: arlinghaus rb. Hematol Pathol. 1993;7(2):91-106. Hematol Pathol. 1993. PMID: 8340287

5

Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells.

Campbell ML, Lu D, Guo JQ, Arlinghaus RB. Campbell ML, et al. Among authors: arlinghaus rb. Cell Growth Differ. 1993 Jul;4(7):581-8. Cell Growth Differ. 1993. PMID: 8398898

6

BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon.

Liu J, Campbell M, Guo JQ, Lu D, Xian YM, Andersson BS, Arlinghaus RB. Liu J, et al. Among authors: arlinghaus rb. Oncogene. 1993 Jan;8(1):101-9. Oncogene. 1993. PMID: 8423987

7

Preparation and application of antibodies to phosphoamino acid sequences.

Sun T, Campbell M, Gordon W, Arlinghaus RB. Sun T, et al. Among authors: arlinghaus rb. Biopolymers. 2001;60(1):61-75. doi: 10.1002/1097-0282(2001)60:1<61::AID-BIP1004>3.0.CO;2-4. Biopolymers. 2001. PMID: 11376433

8

Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.

Guo JQ, Wang JY, Arlinghaus RB. Guo JQ, et al. Among authors: arlinghaus rb. Cancer Res. 1991 Jun 1;51(11):3048-51. Cancer Res. 1991. PMID: 2032243

9

Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death.

Wang Y, Liu J, Wu Y, Luo W, Lin SH, Lin H, Hawk N, Sun T, Guo JQ, Estrov Z, Talpaz M, Champlin R, Arlinghaus RB. Wang Y, et al. Among authors: arlinghaus rb. Cancer Res. 2001 Jan 1;61(1):138-44. Cancer Res. 2001. PMID: 11196151

10

Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia.

Donato NJ, Wu JY, Stapley J, Lin H, Arlinghaus R, Aggarwal BB, Shishodia S, Albitar M, Hayes K, Kantarjian H, Talpaz M. Donato NJ, et al. Cancer Res. 2004 Jan 15;64(2):672-7. doi: 10.1158/0008-5472.can-03-1484. Cancer Res. 2004. PMID: 14744784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters